SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Edderd who wrote (5880)3/12/1998 7:37:00 AM
From: blankmind  Read Replies (2) of 23519
 
You make some good points.

Here's mine:

1. The ED market will be in the billions of dollars.

2. Vivus will hold at least 20 to 30% - even if viagra (which hasn't even been approved yet) - is successful

3. Vivus' 20 to 30% will equat in to $300 - $400 mill per year in revenues - which would be about triple what vivus did last year. Hence - $3 a share in profts - hence - a stock that should be over $40.

4. Time will tell. Shorts are toast. Just my thoughts.

Out.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News